Integrated Biological Evaluation of Benzimidazolium–Chalcone Derivatives: Antioxidant, Anti‐AChE, Anticancer, and Anti‐MRSA Activities With Docking Insights
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.71828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Mehmet Çimentepe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye. Hauptthemen laut MEDLINE: Antineoplastic Agents, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents, Antioxidants. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Four new benzimidazolium–chalcone salt derivatives were synthesized and successfully characterized using 1 H NMR, 13 C NMR, and FT‐IR spectroscopy. Their antioxidant activity, acetylcholinesterase (AChE) inhibitory potential, antibacterial and antibiofilm activities against MRSA and MSSA strains, as well as their anticancer and apoptosis‐inducing properties in human colon adenocarcinoma (HT‐29) cells, were comprehensively evaluated. Among the synthesized compounds, 3a exhibited the strongest antioxidant activity, with IC 50 values of 10.13 ± 0.30 µg/mL in the ABTS assay and 79.40 µg/mL in the DPPH assay, and demonstrated the highest AChE inhibitory effect. Molecular docking analysis further supported these findings, revealing a favorable binding affinity of compound 3a toward the 4EY7 target protein, with a docking score of −8.619 kcal/mol. Antibacterial evaluation using the agar well diffusion method showed that compound 3b produced the largest inhibition zone (19.2 ± 0.6 mm). Consistently, MIC analysis confirmed that 3b displayed potent antibacterial activity against MRSA (MIC: 1 µg/mL) and exhibited the most pronounced antibiofilm effect among the tested derivatives. In cytotoxicity assays, compound 3c demonstrated the highest anticancer activity against HT‐29 cells, with an IC 50 value of 16.7 ± 2.09 µM. Apoptosis analysis revealed that 3c predominantly induced early‐stage apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye.
- Department of Chemistry, Faculty of Science, Eskisehir Technical University, Eskisehir, Türkiye.
- Department of Pharmacy Services, Vocational School of Health Services, Harran University, Sanliurfa, Türkiye.
- Department of Chemistry, Faculty of Art and Science, Cukurova University, Adana, Türkiye.
- Health Services Vocational School Medical Laboratory Techniques Program, Mersin University, Mersin, Türkiye.
- Department of Pharmacology, Faculty of Pharmacy, Harran University, Sanliurfa, Türkiye.
ORCID-Profile: Mehmet Çimentepe, Hakan Ünver, Adem Necip, Mehmet Ersatir, Burcu Demirbağ, Metin Yildirim
Zitieren
APA
Çimentepe, M., Ünver, H., Necip, A., Ersatir, M., Demirbağ, B., Çimentepe, Ö. Ö., & Yildirim, M. (2026). Integrated Biological Evaluation of Benzimidazolium–Chalcone Derivatives: Antioxidant, Anti‐AChE, Anticancer, and Anti‐MRSA Activities With Docking Insights. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.71828
Vancouver
Çimentepe M, Ünver H, Necip A, Ersatir M, Demirbağ B, Çimentepe ÖÖ, et al. Integrated Biological Evaluation of Benzimidazolium–Chalcone Derivatives: Antioxidant, Anti‐AChE, Anticancer, and Anti‐MRSA Activities With Docking Insights. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.71828
BibTeX
@article{imentepe2026,
author = {Çimentepe, Mehmet and Ünver, Hakan and Necip, Adem and Ersatir, Mehmet and Demirbağ, Burcu and Çimentepe, Özge Öztürk and Yildirim, Metin},
title = {Integrated Biological Evaluation of Benzimidazolium–Chalcone Derivatives: Antioxidant, Anti‐AChE, Anticancer, and Anti‐MRSA Activities With Docking Insights},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.71828}
}
EUVIMED